InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Wednesday, 01/13/2021 9:42:38 AM

Wednesday, January 13, 2021 9:42:38 AM

Post# of 241
Don't let these clowns MM steal your shares shorts will be taken to cleaners here you can make book on that.


once you buy your shares lock and key them GTC sky high.


This has a green tech angle to it. do your DD first product hits the market in 2022 with massive revenue potential. A green friendly product that will take profits & market share from Monsanto Roundup product that had 6 billion in sales 2 billion in profits. Also a Cannabis angle. And a next level immunology platform all built on a next level gene editing & AI platform that Cathie Wood from ARKG ETF loves and sees this company scaling and exponential growth on multiple fronts



EVGN Subsidiaries:
Evogene group supports independent entities focusing on a defined commercial field with an exclusive license to use our unique solution for product development.

1.Biomica
https://www.biomicamed.com/
2.Canonic
https://canonicbio.com/
3.AgPlenus
https://www.agplenus.com/
4.Lavie Bio
https://www.lavie-bio.com/
5.Castera
https://www.evogene.com/wp-content/uploads/2019/05/Casterra-company-presentation-ICOA-_pdf-version.pdf



Genome Stocks-Gene Editing.
$PACB 6.2 billion market cap
$BEAM 5.4 billion market cap
$EDIT 4.8 billion market cap
$SGMO 2.3 billion market cap
$NTLA 4.8 billion market cap
$BLUE 3.3 billion market cap
$BNGO 1.2 billion market cap
$EVGN 195 million market cap 35 million shares 45% owned by institutions & insiders




https://www.evogene.com/


$EVGN
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVGN News